Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling.

AIMS: Extensive evidence suggests inflammatory components participate in the pathogenic processes of acute coronary syndromes (ACS). In this study, we aimed to elucidate the role and mechanism underlying the imbalance of Th17 and Treg cell peripheral populations in the pathogenesis of ACS. METHODS A...

Full description

Bibliographic Details
Main Authors: Yanhui Ma, Xiangliang Yuan, Lin Deng, Weiping Xu, Yingxia Zheng, Chaoyan Yue, Guanghui Zhang, Fang Xie, Yuan H Yang, Michael P Gantier, JunPing Liu, Dakang Xu, Lisong Shen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3753235?pdf=render
_version_ 1819132718258061312
author Yanhui Ma
Xiangliang Yuan
Lin Deng
Weiping Xu
Yingxia Zheng
Chaoyan Yue
Guanghui Zhang
Fang Xie
Yuan H Yang
Michael P Gantier
JunPing Liu
Dakang Xu
Lisong Shen
author_facet Yanhui Ma
Xiangliang Yuan
Lin Deng
Weiping Xu
Yingxia Zheng
Chaoyan Yue
Guanghui Zhang
Fang Xie
Yuan H Yang
Michael P Gantier
JunPing Liu
Dakang Xu
Lisong Shen
author_sort Yanhui Ma
collection DOAJ
description AIMS: Extensive evidence suggests inflammatory components participate in the pathogenic processes of acute coronary syndromes (ACS). In this study, we aimed to elucidate the role and mechanism underlying the imbalance of Th17 and Treg cell peripheral populations in the pathogenesis of ACS. METHODS AND RESULTS: Using a flow cytometric analysis, we observed a significantly increased frequency of Th17 cells and a concurrently decreased CD4(+)CD25(+)Foxp3(+) Treg cells in patients with ACS. To elucidate the mechanism of Th17/Treg imbalance in ACS, 22 inflammatory cytokines were measured using multiplexed immunobead-based assays. Of six elevated cytokines in ACS patients, only IL-6 was positively correlated with a higher Th17 cell level (r = 0.39, P<0.01). Relying on IL-6 stimulating and neutralizing studies, we demonstrated a direct role for IL-6 in sera from ACS patients with an increased frequency of Th17 cells. IL-6 induces the differentiation of Th17 cells from naïve CD4(+) T cells through STAT3 activation and RORγt induction. However, we observed that high levels of TGF-β1 inhibited IL-6-dependent Th17 cell differentiation, indicating a complex interplay between the two cytokines in the control of Th17 and Treg cell populations. CONCLUSIONS: Our results demonstrate the role of IL-6-STAT3 signaling in ACS through increased Th17 cell differentiation. These findings indicate that IL-6 neutralizing strategies could present novel therapeutic avenues in the treatment of ACS.
first_indexed 2024-12-22T09:35:51Z
format Article
id doaj.art-99f89deceb2249d2ae846277b240bf73
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T09:35:51Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-99f89deceb2249d2ae846277b240bf732022-12-21T18:30:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0188e7280410.1371/journal.pone.0072804Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling.Yanhui MaXiangliang YuanLin DengWeiping XuYingxia ZhengChaoyan YueGuanghui ZhangFang XieYuan H YangMichael P GantierJunPing LiuDakang XuLisong ShenAIMS: Extensive evidence suggests inflammatory components participate in the pathogenic processes of acute coronary syndromes (ACS). In this study, we aimed to elucidate the role and mechanism underlying the imbalance of Th17 and Treg cell peripheral populations in the pathogenesis of ACS. METHODS AND RESULTS: Using a flow cytometric analysis, we observed a significantly increased frequency of Th17 cells and a concurrently decreased CD4(+)CD25(+)Foxp3(+) Treg cells in patients with ACS. To elucidate the mechanism of Th17/Treg imbalance in ACS, 22 inflammatory cytokines were measured using multiplexed immunobead-based assays. Of six elevated cytokines in ACS patients, only IL-6 was positively correlated with a higher Th17 cell level (r = 0.39, P<0.01). Relying on IL-6 stimulating and neutralizing studies, we demonstrated a direct role for IL-6 in sera from ACS patients with an increased frequency of Th17 cells. IL-6 induces the differentiation of Th17 cells from naïve CD4(+) T cells through STAT3 activation and RORγt induction. However, we observed that high levels of TGF-β1 inhibited IL-6-dependent Th17 cell differentiation, indicating a complex interplay between the two cytokines in the control of Th17 and Treg cell populations. CONCLUSIONS: Our results demonstrate the role of IL-6-STAT3 signaling in ACS through increased Th17 cell differentiation. These findings indicate that IL-6 neutralizing strategies could present novel therapeutic avenues in the treatment of ACS.http://europepmc.org/articles/PMC3753235?pdf=render
spellingShingle Yanhui Ma
Xiangliang Yuan
Lin Deng
Weiping Xu
Yingxia Zheng
Chaoyan Yue
Guanghui Zhang
Fang Xie
Yuan H Yang
Michael P Gantier
JunPing Liu
Dakang Xu
Lisong Shen
Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling.
PLoS ONE
title Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling.
title_full Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling.
title_fullStr Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling.
title_full_unstemmed Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling.
title_short Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling.
title_sort imbalanced frequencies of th17 and treg cells in acute coronary syndromes are mediated by il 6 stat3 signaling
url http://europepmc.org/articles/PMC3753235?pdf=render
work_keys_str_mv AT yanhuima imbalancedfrequenciesofth17andtregcellsinacutecoronarysyndromesaremediatedbyil6stat3signaling
AT xiangliangyuan imbalancedfrequenciesofth17andtregcellsinacutecoronarysyndromesaremediatedbyil6stat3signaling
AT lindeng imbalancedfrequenciesofth17andtregcellsinacutecoronarysyndromesaremediatedbyil6stat3signaling
AT weipingxu imbalancedfrequenciesofth17andtregcellsinacutecoronarysyndromesaremediatedbyil6stat3signaling
AT yingxiazheng imbalancedfrequenciesofth17andtregcellsinacutecoronarysyndromesaremediatedbyil6stat3signaling
AT chaoyanyue imbalancedfrequenciesofth17andtregcellsinacutecoronarysyndromesaremediatedbyil6stat3signaling
AT guanghuizhang imbalancedfrequenciesofth17andtregcellsinacutecoronarysyndromesaremediatedbyil6stat3signaling
AT fangxie imbalancedfrequenciesofth17andtregcellsinacutecoronarysyndromesaremediatedbyil6stat3signaling
AT yuanhyang imbalancedfrequenciesofth17andtregcellsinacutecoronarysyndromesaremediatedbyil6stat3signaling
AT michaelpgantier imbalancedfrequenciesofth17andtregcellsinacutecoronarysyndromesaremediatedbyil6stat3signaling
AT junpingliu imbalancedfrequenciesofth17andtregcellsinacutecoronarysyndromesaremediatedbyil6stat3signaling
AT dakangxu imbalancedfrequenciesofth17andtregcellsinacutecoronarysyndromesaremediatedbyil6stat3signaling
AT lisongshen imbalancedfrequenciesofth17andtregcellsinacutecoronarysyndromesaremediatedbyil6stat3signaling